To Assess the Correlation of High-resolution Specimen PET-CT Imaging, Using the XEOS AURA 10 PET-CT, With the Histopathology Results and Long-term Outcome of Patients Undergoing Resective Cancer Surgery.
Recruiting now
Conditions studied: Prostate Cancers, Breast Cancer, Head and Neck Cancer, Cancer
In brief
This registry study aims to evaluate the effectiveness and clinical impact of specimen PET-CT imaging by analyzing the correlation between specimen PET-CT images, intraoperative interpretations, and histopathological findings. Additionally, it assesses how these imaging insights influence clinical decision-making and long-term patient outcomes. Through this comprehensive analysis in a real-world setting, the study seeks to generate valuable insights that can enhance specimen evaluation processes and ultimately improve patient care.
Key facts
- Study ID
- NCT06970275
- Run by
- XEOS Medical
- People needed
- 850
- Starts
- 2025-11-19
- Expected to finish
- 2031-01-15
- Last updated by the study team
- 2026-07-24
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- All patients that were scheduled for resective surgery and for whom successful high-resolution PET-CT imaging was performed on their resected specimens using the AURA 10 PET-CT. Successful imaging means that the image contains at least a portion of the primary tumor, the radiotracer injection was correctly executed and there were no technical issues that lead to an uninterpretable PET-CT image. Or all patients that are scheduled for resective surgery and for whom high-resolution PET-CT imaging will be performed on their resected specimens using the AURA 10 PET-CT.
- Patients willing to provide informed consent for use of their relevant medical records. For retrospectively included patients with no further Long-Term Follow-Up (LTFU) data collection, a notification will be sent.
You may not qualify if…
- Under the age of 18 years at the time of resective surgery.
- Women who are pregnant or breastfeeding.
Where it is running
- AZ Maria Middelares — Ghent, Belgium (enrolling)
- Universitäts-klinikum Essen — Essen, North Rhine-Westphalia, Germany (enrolling)
- University Hospitals Coventry and Warwickshire (UHCW) NHS Trust — Coventry, West Midlands, United Kingdom (enrolling)
- UMCG — Groningen, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.